{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444524924
| IUPAC_name = O5-methyl O3-[(3''R'')-1-(phenylmethyl)piperidin-3-yl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
| image = Benidipine structure.svg
| alt = Skeletal formula of benidipine
| width = 250px
| image2 = Benidipine-3D-balls.png
| alt2 = Ball-and-stick model of the benidipine molecule

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|benidipine}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
|  PubChem = 656668
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 571013
|  smiles = [O-][N+](=O)c1cccc(c1)[C@@H]4C(/C(=O)OC)=C(\N\C(=C4\C(=O)O[C@@H]3CCCN(Cc2ccccc2)C3)C)C
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C28H31N3O6/c1-18-24(27(32)36-3)26(21-11-7-12-22(15-21)31(34)35)25(19(2)29-18)28(33)37-23-13-8-14-30(17-23)16-20-9-5-4-6-10-20/h4-7,9-12,15,23,26,29H,8,13-14,16-17H2,1-3H3/t23-,26-/m1/s1
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = QZVNQOLPLYWLHQ-ZEQKJWHPSA-N
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 105979-17-7
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2218858
| ATC_prefix = C08
| ATC_suffix = CA15
| ATC_supplemental =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 4G9T91JS7E

<!--Chemical data-->
| C=28 | H=31 | N=3 | O=6 
| molecular_weight = 505.562 
}}

'''Benidipine''' ([[International Nonproprietary Name|INN]]), also known as Benidipinum or benidipine hydrochloride, is a dihydropyridine calcium channel blocker for the treatment of [[Hypertension|high blood pressure (hypertension)]]. It is a triple <small>L</small>-, <small>T</small>-, and <small>N</small>-type [[calcium channel blocker]]. It is reno- and cardioprotective.

== Dosing ==
Benidipine is dosed as 2–8&nbsp;mg once daily.<ref>{{cite web | url = http://www.mims-online.com/Page.aspx?menuid=mng&name=Coniel%20film-coated%20tab | title = Coniel (benidipine) package insert (Philippines) | author = Hi-Eisai Pharmaceutical, Inc. | accessdate = 2008-03-31 | publisher = CMPMedica | work = MIMS Philippines}}</ref>

== Availability ==
Benidipine is sold as '''Coniel''' by Kyowa Hakko Kogyo.

Benidipine is only licensed for use in Japan and selected [[South East Asia|Southeast Asian]] countries, where it is sold as 4&nbsp;mg tablets.

==Mechanism==
Benidipine is a [[calcium channel blocker]].

Benidipine has additionally been found to act as an [[receptor antagonist|antagonist]] of the [[mineralocorticoid receptor]], or as an [[antimineralocorticoid]].<ref name="Luther2014">{{cite journal|last1=Luther|first1=James M.|title=Is there a new dawn for selective mineralocorticoid receptor antagonism?|journal=Current Opinion in Nephrology and Hypertension|volume=23|issue=5|year=2014|pages=456–461|issn=1062-4821|doi=10.1097/MNH.0000000000000051}}</ref>

== References ==
{{Reflist|2}}


{{Channelergics}}
{{Mineralocorticoidics}}

[[Category:Antimineralocorticoids]]
[[Category:Aldosterone synthase inhibitors]]
[[Category:Calcium channel blockers]]
[[Category:Carboxylate esters]]
[[Category:Dihydropyridines]]
[[Category:Methyl esters]]
[[Category:Nitrobenzenes]]
[[Category:Piperidines]]